{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:18:56Z","timestamp":1740460736615,"version":"3.37.3"},"reference-count":7,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2023,12,8]]},"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1183\/13993003.01392-2023","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T09:45:20Z","timestamp":1709199920000},"page":"2301392","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Supporting the case for a targeted approach for elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis with no F508del CFTR variant: further analysis for the French compassionate use programme"],"prefix":"10.1183","volume":"63","author":[{"given":"Michael","family":"Dooney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"2024102017213850000_63.2.2301392.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02437-2022"},{"key":"2024102017213850000_63.2.2301392.2","unstructured":"L'Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) . D\u00e9cision du 01\/06\/2023 \u2013 Extension de l'indication du cadre de prescription compassionnelle de Kaftrio (ivacaftor, tezacaftor, \u00e9lexacaftor) et Kalydeco (ivacaftor). [Decision of 01\/06\/2023 \u2013 Extension of the indication of the compassionate prescription framework of Kaftrio (ivacaftor, tezacaftor, \u00e9lexacaftor) and Kalydeco (ivacaftor).]. Date last updated: 1 June 2023. https:\/\/ansm.sante.fr\/actualites\/decision-du-01-06-2023-extension-de-lindication-du-cadre-de-prescription-compassionnelle-de-kaftrio-ivacaftor-tezacaftor-elexacaftor-et-kalydeco-ivacaftor"},{"key":"2024102017213850000_63.2.2301392.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2024102017213850000_63.2.2301392.4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017213850000_63.2.2301392.5","unstructured":"Vertex Pharmaceuticals . Trikafta SmPC. Updated June 2021. Date last accessed: 7 August 2023. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/212273s004lbl.pdf"},{"key":"2024102017213850000_63.2.2301392.6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jcf.2023.06.001","article-title":"Clinical and functional efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis carrying the N1303K mutation","volume":"22","author":"Sadras","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2024102017213850000_63.2.2301392.7","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.3390\/ijms241210358","article-title":"Theratyping of the rare CFTR genotype A559T in rectal organoids and nasal cells reveals a relevant response to elexacaftor (VX-445) and tezacaftor (VX-661) combination","volume":"24","author":"Kleinfelder","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01392-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:18:02Z","timestamp":1740381482000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01392-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,29]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1183\/13993003.01392-2023"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01392-2023","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}